Dana Yaacov-Garbeli - Apr 19, 2024 Form 4/A Insider Report for Entera Bio Ltd. (ENTX)

Role: Chief Financial Officer
Signature: /s/ Dana Yaacov-Garbeli
Stock symbol: ENTX
Transactions as of: Apr 19, 2024
Transactions value $: $0
Form type: 4/A
Date filed: 8/2/2024, 04:31 PM
Date Of Original Report: Apr 23, 2024
Previous filing: Apr 25, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENTX	Ordinary Shares, par value NIS 0.0000769 per share	Award	$0	+30.2K	+53.29%	$0.00	86.7K	Apr 19, 2024	By A2Z Counseling Ltd.	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENTX	Stock Option (right to buy)	Award	$0	+130K		$0.00	130K	Apr 19, 2024	Ordinary Shares, par value NIS 0.0000769 per share	130K	$1.99	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represent a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024.
F2	On April 23, 2024, the reporting person filed a Form 4 which inadvertently reported that the reporting person's ordinary shares and restricted stock units are held directly.
F3	These shares are owned by A2Z Counseling Ltd. of which the reporting person owns a 33.33% interest and has effective control over voting and disposition of the shares. The reporting person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F4	The options vest over a three-year period with 33% of the options vesting on April 19, 2025, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period.